Close Menu

NanoString

NanoString Technologies has appointed Gary Riordan as vice president of quality and regulatory affairs and Kathy Surace-Smith as VP and general counsel.

NanoString Kicks off Global Marketing of Prosigna Gene Signature Assay

Using NanoString's nCounter technology, researchers from Pfizer and Seoul National University have developed an ALK test they hope will be as accurate as the gold standard fluorescence in situ hybridization test for identifying patients who could benefit from Pfizer's Xa

The following is a summary of studies exploring personalized treatment strategies in breast cancer that were presented at the San Antonio Breast Cancer Symposium, held Dec. 4-8.

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it has raised $15.3 million in a Series E Preferred Stock round of financing.

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Wednesday that its third-quarter revenues increased 21 percent year over year driven by strong consumables growth.

BD Diagnostics said that Paul Borbeau has joined the company as director of North American scientific affairs for diagnostic systems.

NEW YORK (GenomeWeb News) – NanoString Technologies has obtained the CE Mark for its PAM50-based gene expression test for breast cancer, clearing the firm to sell the test in the European Union and other countries that recognize the CE Mark.

NanoString has launched the nCounter Single Cell Assay, a single-cell gene expression application for its nCounter digital detection and counting system.

NanoString Technologies this week launched an application for single-cell gene-expression profiling.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.